P. Assouline

Efficacy and safety of anti-PD-1 immunotherapy in patients with advanced Non Small Cell Lung Cancer with BRAF, HER2 or MET mutation or RET-translocation. GFPC 01-2018.

P. Fournel, F. Guisier, C. Chouaid, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Primary mediastinal germ cell tumors. Results of a French retrospective study.

P. Diot, E. Lemarié, J. Droz, 1992, Chest.

[Breast metastases from lung cancers with the EGFR mutation].

A. Lemoine, J. Hamelin, R. Saffroy, 2017, Revue des maladies respiratoires.

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)

D. Damotte, F. Guisier, R. Lamy, 2020, OncoTargets and therapy.

OTT_A_288825 13299..13305

D. Damotte, F. Guisier, R. Lamy, 2020 .

[Primary malignant germinal tumors of the mediastinum. Results from a national retrospective survey].

P. Diot, E. Lemarié, J. Régnard, 1992, Revue des maladies respiratoires.

Mtastases chorodiennes des cancers broncho-pulmonaires

M. Humbert, G. Oliviero, P. Assouline, 2004 .